Moleculin Biotech (MBRX) Common Equity (2015 - 2026)
Moleculin Biotech (MBRX) reported Common Equity of $11.59 million for Q2 2026, compared with -$3,585 a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech posted Common Equity of $15.01 million, up 33.9% from FY2024.
- Common Equity has a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- By year, Common Equity came in at $11.21 million in FY2024 (-63.8%), $30.93 million in FY2023 (-40.7%), $52.19 million in FY2022 (-33.9%) and $78.99 million in FY2021 (+344.8%).
- Five-year quarterly Common Equity spans a low of -$26.92 million in Q3 2025 and a high of $81.26 million in Q3 2021.
- Year over year, Common Equity gained in 1 of the last four quarters, with an average decline of 31.3%.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 461.7%); the low point was Q4 2024 (a decline of 63.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Moleculin Biotech | 3.24 Mn | 3.24 Mn | - | 11.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.59 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Sep 30, 2025 | -26.92 Mn |
| Jun 30, 2025 | -3,585.00 |
| Mar 31, 2025 | 13.79 Mn |
| Dec 31, 2024 | 11.21 Mn |
| Sep 30, 2024 | 17.41 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 24.99 Mn |
| Dec 31, 2023 | 30.93 Mn |
| Sep 30, 2023 | 35.14 Mn |
| Jun 30, 2023 | 40.27 Mn |
| Mar 31, 2023 | 45.68 Mn |
| Dec 31, 2022 | 52.19 Mn |
| Sep 30, 2022 | 58.42 Mn |
| Jun 30, 2022 | 66.36 Mn |
| Mar 31, 2022 | 72.67 Mn |
| Dec 31, 2021 | 78.99 Mn |
| Sep 30, 2021 | 81.26 Mn |
| Jun 30, 2021 | 84.70 Mn |
API Access
Moleculin Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();